Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Sandoz Limited, Park View, Riverside Way, Watchmoor Park, Camberley, Surrey, GU15 3YL, United Kingdom
Ceptava 180 mg Gastro-resistant Tablets.
| Pharmaceutical Form |
|---|
|
Gastro-resistant tablet. Lime green film-coated round tablets with bevelled edges and the imprint (debossing) ‘C’ on one side. Dimensions: approximately 10.4 × 4.2 mm. |
Each gastro-resistant tablet contains 180 mg of mycophenolic acid (as mycophenolate sodium).
Excipients with known effect:
Each gastro-resistant tablet contains 12.93 mg of sodium (as mycophenolate sodium) and 45 mg of lactose (anhydrous).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Mycophenolic acid |
Mycophenolic acid is a potent, selective, uncompetitive and reversible inhibitor of inosine monophosphate dehydrogenase, and therefore inhibits the de novo pathway of guanosine nucleotide synthesis without incorporation into DNA. Mycophenolic acid has more potent cytostatic effects on lymphocytes than on other cells and is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in adult patients receiving allogeneic renal transplants. |
| List of Excipients |
|---|
|
Core: Lactose, anhydrous Coating: Hypromellose phthalate HP 50 |
PA/AL/PVC-aluminium blister packs.
Pack sizes:
20, 50, 100, 120, 250 gastro-resistant tablets.
Not all pack sizes may be marketed.
Sandoz Limited, Park View, Riverside Way, Watchmoor Park, Camberley, Surrey, GU15 3YL, United Kingdom
PL 04416/1467
Date of first authorisation: 15 December 2016
| Drug | Countries | |
|---|---|---|
| CEPTAVA | Spain, Italy, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
